p53dependence of topoisomerase I recruitment in vivo

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4538-4543

  Mao, Yinghui ^a   Okada, Shoshiro ^a   Chang, Long Sheng ^b   Muller, Mark T ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); PROTEIN P53;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CELL CYCLE; CYCLOHEXIMIDE; DNA; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; HL-60 CELLS; HUMANS; ISOENZYMES; PROTEIN SYNTHESIS INHIBITORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034662642     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Growth factor modulation of p53-mediated growth arrest versus apoptosis
2. The two faces of tumor suppressor p53
3. DNA damage and cell cycle checkpoint
4. Tumor suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage
5. The regulation of p53 function: Steiner Award Lecture
6. The Walter Habert Lecture: The role of the p53 tumor-suppressor gene in tumorigenesis
7. p53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation
8. Fas ligand: A sensor for DNA damage critical in skin cancer etiology
9. Interaction of the p53-regulate protein GADD45 with proliferating cell nuclear antigen
10. p53 modulation of TFIIH-associated nucleotide excision repair activity
11. Wild-type and mutant forms of p53 activate human topoisomerase I: A possible mechanism for gain of function in mutants
12. Modulation of DNA topoisomerase I activity by p53
13. A model for the mechanism of human topoisomerase I
14. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA
15. DNA topoisomerase I is involved in both repression and activation of transcription
16. DNA looping alters local DNA conformation during transcription
17. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II
18. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells
19. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons
20. The role of DNA topoisomerases in recombination and genome stability: A double-edged sword
21. DNA topoisomerase: Why so many
22. Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae
23. DNA topoisomerases
24. Genetics of DNA topoisomerases
25. DNA topoisomerase I is essential in Drosophila melanogaster
26. Targeted disruption of the mouse topoisomerase I gene by camptothecin selection
27. Inhibition of Micrococcus luteus DNA topoisomerase I by UV photoproducts
28. Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I
29. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: Possible relationship with DNA repair
30. Geldanamycin selectively destabilizes and conformationally alters mutated p53
31. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
32. Direct sequencing from touch preparations carcinomas: Analysis of p53 mutation in breast carcinomas
33. Analysis of topoisomerase I/DNA complexes in patients administered topotecan
34. ICE bioassay: Isolating in vivo complexes of Enzyme to DNA
35. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin
36. Action of camptothecin on mammalian cells in culture
37. DNA topoisomerase poisons as antitumor drugs
38. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant cells
39. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells
40. Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development
41. Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage